This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Deutsche Biotech Innovativ Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Deutsche Biotech Innovativ.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth	40.9%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Deutsche Biotech Innovativ has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

MUN:DBI - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	N/A	-1	-1	0	N/A
12/31/2022	0	0	0	0	N/A
12/31/2021	N/A	0	0	0	N/A
12/31/2020	N/A	0	0	0	N/A
6/30/2020	N/A	0	0	0	N/A
3/31/2020	N/A	0	0	0	N/A
12/31/2019	N/A	0	0	0	N/A
9/30/2019	0	0	0	0	N/A
6/30/2019	0	0	0	0	N/A
3/31/2019	0	0	0	0	N/A
12/31/2018	0	0	0	0	N/A
9/30/2018	0	0	0	0	N/A
6/30/2018	0	0	0	0	N/A
3/31/2018	0	0	0	0	N/A
12/31/2017	0	0	0	0	N/A
9/30/2017	0	0	N/A	N/A	N/A
6/30/2017	0	0	N/A	0	N/A
3/31/2017	0	0	N/A	0	N/A
12/31/2016	0	0	N/A	0	N/A
9/30/2016	0	0	N/A	N/A	N/A
6/30/2016	0	0	N/A	-1	N/A
3/31/2016	0	-1	N/A	-1	N/A
12/31/2015	0	-1	N/A	-1	N/A
9/30/2015	0	0	N/A	0	N/A
6/30/2015	0	0	N/A	0	N/A
3/31/2015	0	0	N/A	0	N/A
12/31/2014	0	0	N/A	0	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if DBI's forecast earnings growth is above the savings rate (0.8%).

Earnings vs Market: Insufficient data to determine if DBI's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if DBI's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if DBI's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if DBI's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if DBI's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/10/01 22:23
End of Day Share Price	2024/10/01 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Deutsche Biotech Innovativ AG is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Simon Scholes	First Berlin Equity Research GmbH